Jonathan Brotchie

Company: Atuka

Job title: Chief Executive Officer

Seminars:

Targeting Protein Degradation in Parkinson’s: a preclinical perspective 2:00 pm

Therapeutic Landscape and Future Directions – Reviewing current and emerging drug development strategies targeting protein degradation in Parkinson’s. Pathological vs. Non-Pathological Proteins – Addressing tactics for targeting synuclein protein aggregation vs degradation of proteins that drive synuclein pathology Animal Models for Enhancing Protein Degradation – Overview of rodent and non-human primate models used in preclinical…Read more

day: Conference Day One